Less Ads, More Data, More Tools Register for FREE

Pin to quick picksConygar Inv Regulatory News (CIC)

Share Price Information for Conygar Inv (CIC)

Share Price is delayed by 15 minutes
Get Live Data
23.50    0.00 (0.00%)
Bid:
23.00
Ask:
24.00
Spread: 1.00 (4.348%)
Market Cap: £14.02m
CIC Live PriceLast checked at - London Stock Exchange

Intraday Conygar Inv Share Chart

ZDP Share Acquisition Programme

22 Jan 2026 07:00

RNS Number : 8629P
Conygar Investment Company PLC(The)
22 January 2026
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO ANY US PERSONS OR INTO THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN, OR ANY OTHER JURISDICTION, OR TO ANY PERSON, WHERE DOING SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

 

22 January 2026

 

THE CONYGAR INVESTMENT COMPANY PLC (THE "COMPANY")

 

CONYGAR ZDP PLC (THE "ISSUER")

 

ZDP Share Acquisition programme 

The Conygar Investment Company PLC announces the commencement of a share acquisition programme (the "Programme") of the zero dividend preference shares ("ZDP Shares") in the capital of the Issuer currently admitted to the Official List of the International Stock Exchange.

The Company has appointed Panmure Liberum Limited as its broker and Liberum Wealth Limited as its agent to purchase ZDP Shares, up to a maximum aggregate consideration of £2,500,000. ZDP Shares will be acquired at a share price up to the Accrued Capital Entitlement of each ZDP Share on the date of the transaction.

The Programme will be funded by the Company's cash reserves. It is anticipated that any ZDP Shares purchased within the Programme will remain held by the Company until the ZDP Repayment Date.

Any purchase of the ZDP Shares contemplated by this announcement will be carried out outside of a regulated market or multilateral trading facility.

The Company has authorised the Programme to commence from today and continue until 3 March 2026.

Details of purchases of any ZDP Shares made by the Company will be notified to a Regulatory Information Service by the Company following any acquisition as required by the Market Abuse Regulation.

This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.

Capitalised terms used but not defined in this announcement have the meaning given to them in the listing document published by the Issuer on 3 October 2023.

Enquiries:

 

The Conygar Investment Company PLC

Robert Ware / David Baldwin: 020 7258 8670 

 

Panmure Liberum (Nominated Adviser and Broker)

Chris Clarke / Jamie Richards: 020 3100 2185

 

Temple Bar Advisory (Public Relations)

Alex Child-Villiers: 07795 425580

Sam Livingstone: 07769 655437

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUASRRNOUAUUR
Date   Source Headline
21st Aug 20091:53 pmRNSOffer unconditional as to acceptances
21st Aug 20098:44 amRNSEPT Disclosure
19th Aug 20099:51 amRNSEPT Disclosure
18th Aug 200910:32 amRNSRule 2.10 Announcement
18th Aug 200910:29 amRNSRule 8.1- The Conygar Investment Company PLC
18th Aug 200910:25 amRNSExercise of Options
18th Aug 20098:42 amRNSEPT Disclosure
13th Aug 200910:52 amRNSSch 1 - The Conygar Investment Co. plc
13th Aug 20098:55 amRNSEPT Disclosure
10th Aug 200911:27 amRNSEPT Disclosure
7th Aug 200910:09 amRNSEPT Disclosure
6th Aug 20095:50 pmRNSRule 8.3- Conygar Investment Co. Plc
31st Jul 200910:35 amRNSEPT Disclosure
24th Jul 20097:00 amRNSRule 8.3- Conygar Investment Company Plc
14th Jul 200911:57 amRNSRule 8.3- Conygar Investment Company Plc
14th Jul 200911:47 amRNSRule 8.1- (The Conygar Investment Company PLC)
13th Jul 20099:10 amRNSRule 8.1- (The Conygar Investment Company PLC)
10th Jul 200911:49 amRNSRule 8.1- (The Conygar Investment Company PLC)
6th Jul 200911:49 amRNSRule 8.1- The Conygar Investment Company PLC
18th Jun 20099:39 amRNSRule 8.1- The Conygar Investment Company PLC
17th Jun 200911:40 amRNSRule 8.1- The Conygar Investment Company PLC
15th Jun 200910:20 amRNSRule 8.1- The Conygar Investment Company PLC
8th Jun 200911:22 amRNSRule 8.1- The Conygar Investment Company PLC
5th Jun 200910:46 amRNSRule 8.1- The Conygar Investment Company PLC
3rd Jun 200911:48 amRNSRule 8.1- The Conygar Investment Company PLC
14th May 20097:00 amRNSInterim Results
20th Apr 20093:24 pmRNSHolding(s) in Company
26th Feb 20098:58 amRNSDirector/PDMR Shareholding
6th Feb 20093:28 pmRNSShareholder Notification
6th Feb 200911:44 amRNSResult of AGM
8th Dec 20083:41 pmRNSDirector/PDMR Shareholding
8th Dec 20083:39 pmRNSDirector/PDMR Shareholding
3rd Dec 20087:00 amRNSFinal Results
13th Aug 20083:34 pmRNSDirector/PDMR Shareholding
13th Aug 20083:32 pmRNSDirector/PDMR Shareholding
26th Jun 20083:35 pmRNSDirector/PDMR Shareholding
26th Jun 200812:10 pmRNSDirector/PDMR Shareholding
11th Jun 200811:29 amRNSDirector/PDMR Shareholding
3rd Jun 20087:00 amRNSInterim Results
8th May 20086:18 pmRNSHolding(s) in Company
30th Apr 20087:01 amRNSTotal Voting Rights
31st Mar 200812:02 pmRNSAcquisition
22nd Feb 200810:48 amRNSPlanning Approval
30th Jan 20084:20 pmRNSResult of AGM
9th Jan 200811:28 amRNSPlanning Update
10th Dec 20077:00 amRNSFinal Results
22nd Oct 20077:01 amRNSJoint Venture
31st Aug 20077:01 amRNSChange of Adviser
8th Aug 20079:16 amRNSRule 26 Notification
25th Jun 20073:57 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.